Connect with us

General News

How Will the Government Support Cannabis Research?

Published

on

pop culture enthusiasts

Dick Durban is the first Senator in the United States to initiate a legislation that would be encouraging cannabis research on the federal level.

The new act is the Expanding Cannabis Research and Information Act according to which there will be complete allowance of research on cannabis federally.

It will be expanding studies on the pros and cons of cannabis use. Scientists in 2017 conducted a study on the current situation of research on cannabis via National Academies of Sciences, Engineering and Medicine.

They found that cannabis is beneficial for coping many medical conditions. However, there is a lack of evidence-based research considering its side effects and harms. There is a narrow scape for research on the public health and safety effects from cannabis usage.

More room for advanced research

Over thirty US states have now legalized cannabis in some sort. With the lift from the federal ban, there will be room for cutting edge medicinal research on cannabis. There will be an in-depth understanding of cannabis usage for treating a specific population with disease. These target groups include pregnant women, children and elderly as well.

The federal law considers cannabis and its compounds to be Schedule I controlled substances according to the Drug Enforcement Administration DEA. It further states that cannabis does not have any medical benefit.

The classification implies limitations on cannabis accessibility and usage for research. Scientists will have to undergo many twisting procedures of regulations for every new research on cannabis.

It includes getting cannabis strains through the National Institutes of Health and licenses from the Drug Enforcement Agency. These are formalities in addition to the basic prerequisites.

It has made many conflicts in which many scientists were unable to conduct studies even in states where cannabis was fully available for all purposes.

What will the act imply?

It will be under the consideration of the act to direct these major authorities and regulatory bodies to develop an agenda for cannabis research on national scale. This will be prioritizing fundamental queries and loopholes in evidence.

Furthermore, it will include a study of diseases cannabis can cure effectively. In addition, it will study how cannabis influences susceptible population.

Moreover, there will be a study of long-term effects, delivery modes and addressing public safety concerns.

It will be directing higher authorities to acquire data on cannabis usage and its impact on public health. Surveys and analyses of medical records will help expanding data collection of public health about outcomes and product types.

Cannabis will now have an image of a schedule III instead of a schedule I substance under the Drug Enforcement Administration. It will lift barriers that scientists face while having access to cannabis.

The Centers of Excellence designation established through NIH would help streamline the research pathway. It will enabling universities to have a DEA inspection that would last around five to ten years. This will omit the need for specific approvals for every study.

In addition, it will be also expanding permissible suppliers for cannabis cultivation for research purposes.

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

United Kingdom has still a long way to go before legalizing cannabis in the country

Published

on

united kingdom

Though the United Kingdom is in favor of cannabis legalization, it is still illegal in the country. Let us go through the marijuana sector of the United Kingdom.

Some facts about cannabis consumption in the United Kingdom 

The people residing in the United Kingdom strongly favor the legalization of cannabis. But it is limited only to the back door market. There are more than 2.5 million cannabis users in the UK who buy it illegally as reported by the Cannabis Consultancy Prohibition Partners. It makes up almost 4% of the total population of the United Kingdom carrying a worth of more than £5 billion. 

It is important to note that 22% of the country’s population smokes tobacco, which makes up the revenue of almost £18 billion annually. Whereas, 60% population of the country drinks alcohol regularly ranging a worth of almost £68 billion. 

Legalization of cannabis in the United Kingdom

In 2018, the UK legalized the use of cannabis for medical purposes. The major reason behind its regulation was many high-profile cases of epilepsy in children came to light. Cannabis-related medications became the pain reliever for those patients suffering from such high profile epilepsy cases. Still, the use of cannabis for medical purposes is extremely less. 

Only the specialist consultant from General Hospital can prescribe it. The UK also allowed hemp oil and CBD, containing less than 0.2% THC, in the country. But a medical license is mandatory for using them too.

 Which country is the largest exporter and producer of legal marijuana across the globe?

Although the stance of the government of the United Kingdom is much strict for cannabis users, it is the largest exporter as well as the largest producer of legal medical marijuana in the world according to the reports of United Nations International Narcotics Control Board. This clearly shows that the UK exports all the legal cannabis products manufactured by the country.

There are only two products of medical marijuana in the UK that have a license. One is Sativex which is produced by GW Pharmaceuticals and the other one is Nabilone owned by Eli Lilly. 

The contradictory policy of the United Kingdom

It is evident from all the facts mentioned above that the government of the United Kingdom is still confused about whether to legalize marijuana in the country or not. While it is the largest exporter and producer of cannabis, it is very tough for patients of the country to have access to the products of medical cannabis. 

This shows the sanctimonious face of the country and it would probably cause difficulties for the cannabis industry in England including the monopoly of licensed manufacturers, high cost and barriers for the new entrants.

Some top-notch stocks of the United Kingdom

Though there are many difficulties for marijuana companies in the UK, there is a large range of public companies. According to the London Stock Exchange, most companies have other side businesses too other than cannabis. Some top cannabis stocks of the United Kingdom are GW Pharmaceuticals, Futura Medical, Integumen, AfriAg, and Sunrise Resources.

Continue Reading

Cannabis

New Jersey still waiting to Regulate Cannabis for Recreational Purposes

Published

on

new jersey

The members of the Senate of New Jersey were going to vote on the bill of expungement on September 12. This bill was related to the convicts of marijuana and also involved some recommendations from Governor Philip D. Murphy.

But, as mentioned by one of the articles of NJ Advance Media, Senators including Teresa Ruiz, Sandra Cunningham and Stephen Sweeney, the President of the Senate of New Jersey, launched a new legislation. In light of the article, the new legislation will widen the restrictions on the offenders charged with cannabis-related offenses to entreat expungement.

But the bill could not pass because the Democrats failed to gather enough support in the Senate on 12th September.

History of marijuana legalization in New Jersey

In New Jersey, only medical cannabis is legal yet. Though Governor Philip D. Murphy along with other Democrats tried several times to regulate recreational cannabis, they failed to gather enough support to pass the bill.

Governor Corzine signed the Compassionate Use Medical Cannabis Act of New Jersey in 2010 to regulate marijuana for patients suffering from chronic illness. This year, Governor Philip Murphy passed the Jake Honig Law. This law relieved the restrictions including the amount of medical marijuana any patient could buy and the number of visits to physicians required to purchase it.

For recreational marijuana, Senator Scutari first launched a bill on 17th May to regulate adult-use marijuana. But the Governor of New Jersey at that time, Chris Christie, opposed this legalization. As a consequence, the bill rejected. When Murphy was elected as the Governor of New Jersey, he launched a campaign to regulate marijuana in the state. Governor Philip Murphy had full control of the Democrats in the Senate as well as in the Assembly. But he could not succeed to legalize recreational cannabis. The major reason for failure was the disharmony among the party. Also, African American members of the senate strongly opposed this bill.

The people residing in New Jersey favor the regulation of adult-use cannabis. According to the Cannabis Business Executive, a survey conducted by Monmouth University suggested that 62% of adults of the state were in favor to legalize a small amount of marijuana in possession for recreational purposes. The survey also indicated that 74% of the adults were in favor to remove the charges on offenders charged for cannabis-related offenses. In the United States of America, 33 states have legalized the use of medical cannabis. Whereas, only 11 states including Oregon, Massachusetts, Alaska, and California have allowed recreational marijuana.

Some advantages of the legalization

There are many advantages of legalizing marijuana for recreational purposes. It would not only create new job opportunities but also increase tax revenue. According to the article of NJ Advance Media, the Governor of New Jersey believes that $80 million would be collected by the state as a cannabis tax revenue in the upcoming year. It involves $20 million from cannabis for health purposes and $60 million from cannabis for recreational purposes. This regulation will also allow cannabis companies to enlarge their businesses across the state.

 

 

Continue Reading

General News

This University is Launching a Cannabis Program!

Published

on

university

Medical cannabis has gained highlight, even in the academic ground. The University of Maryland is going to be the first US university to be offering a graduate program in medical cannabis.

The program will be offering the students an in-depth insight into the medical management of cannabis patients. Moreover, there will be an extensive study for continuing research in the field.

This will be giving a new way to transform policies regarding medical cannabis. The program will be for two years for the students of the university.

Status of cannabis in different US states

Thirty-three states in the US have legalized medical cannabis. The number will be increasing in the coming time. There will be more jobs opening up in the industry.

Since quite a while, individuals did not more often than not discuss it. In any case, presently, cannabis has compelled its way into the standard. In the United States energy toward wide based legitimization stayed at just 25% in 1995. Now, an unequaled record number of people by and by the need to see pot approved in an extensive range.

The overall expansion has been likewise as exceptional. A year back, worldwide weed arrangements hit $12.2 billion. There are in like manner over 40 countries worldwide to have waved the green flag on restorative cannabis.

A couple of things will happen before the legitimate weed industry has any shot at $166 billion in yearly arrangements. This consolidates keeping an eye on the enormous contraband market by approving cannabis in the United States and different countries.

Numerous individuals need to devour cannabis only for recreational purposes. To include further, the item can turn out to be so promptly accessible in each home in each room. Odds are it will lose its substance simply as some other conventional painkiller did. The inquiry still stays unanswered on the vulnerability of the dimension of the utilization of the item.

Be that as it may, researchers can examine thoroughly the employment of exceedingly significant dynamic elements of the substance. This way, they will be better ready to coordinate for the making of exact items explicitly intended to manage certain issues.

How will this graduate programs benefit people?

The graduates will be able to pursue a career in the medical cannabis space. Also, another fact about this program is that it will be benefiting professionals in medical and health sciences. Industry related people will be able to dive deeper into certain aspects of medical cannabis.

Many pharmacists will be able to manage better the new products coming in the market from this emerging industry. The courses will be acting as an integral tool for providing students with the knowledge they need to know about the subject.

Most of the course will be constituted of online classes. This way, more professionals who have their work shifts during the day can easily manage the course. The understanding of the course is easy even for people who do not link with medicinal studies.

The students will be able to better support not only the clinical setup but also the industries in respect to cannabis use.

Continue Reading

Trending